Treatment of Severe Hyponatremia
Department
Medicine
Document Type
Article
Publication Title
Clinical Journal Of The American Society Of Nephrology
Abstract
Patients with severe (serum sodium ≤120 mEq/L), symptomatic hyponatremia can develop life-threatening or fatal complications from cerebral edema if treatment is inadequate and permanent neurologic disability from osmotic demyelination if treatment is excessive. Unfortunately, as is true of all electrolyte disturbances, there are no randomized trials to guide the treatment of this challenging disorder. Rather, therapeutic decisions rest on physiologic principles, animal models, observational studies, and single-patient reports. European guidelines and recommendations of an American Expert panel have come to similar conclusions on how much correction of hyponatremia is enough and how much is too much, but there are important differences. We review the evidence supporting these recommendations, identifying areas that rest on relatively solid ground and highlighting areas in greatest need of additional data.
First Page
641
Last Page
649
DOI
10.2215/CJN.10440917
Volume
13
Issue
4
Publication Date
4-6-2018
Medical Subject Headings
Acute Disease; Brain Edema (etiology); Chronic Disease; Demyelinating Diseases (chemically induced); Hyponatremia (blood, complications, therapy); Practice Guidelines as Topic; Saline Solution (administration & dosage, adverse effects); Severity of Illness Index; Sodium (adverse effects, blood)
PubMed ID
29295830
Recommended Citation
Sterns, R. H. (2018). Treatment of Severe Hyponatremia. Clinical Journal Of The American Society Of Nephrology, 13 (4), 641-649. https://doi.org/10.2215/CJN.10440917